Vertex Pharmaceuticals (VRTX) News Today $484.24 +3.91 (+0.81%) Closing price 04:00 PM EasternExtended Trading$486.92 +2.68 (+0.55%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $408.00Royal Bank of Canada lifted their target price on Vertex Pharmaceuticals from $407.00 to $408.00 and gave the company a "sector perform" rating in a research note on Thursday.February 21 at 12:01 PM | marketbeat.comVertex Pharmaceuticals Q4 Earnings TranscriptFebruary 21 at 7:19 AM | marketbeat.comHandelsbanken Fonder AB Sells 115,479 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Handelsbanken Fonder AB trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 28.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 296,036 shares of the pharmaFebruary 21 at 6:07 AM | marketbeat.com2 No-Brainer Healthcare Stocks to Buy With $500 Right NowFebruary 21 at 5:50 AM | fool.comIeq Capital LLC Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Ieq Capital LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,223 shares of the pharmaceutical company's stock after sellingFebruary 21 at 4:45 AM | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com to "Hold"StockNews.com lowered Vertex Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Wednesday.February 20 at 11:08 PM | marketbeat.comInsider Sell: Jonathan Biller Sells Shares of Vertex Pharmaceuticals Inc (VRTX)February 20 at 9:55 PM | gurufocus.comInsider Selling: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) EVP Sells 244 Shares of StockVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) EVP Ourania Tatsis sold 244 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $455.06, for a total transaction of $111,034.64. Following the completion of the sale, the executive vice president now owns 67,695 shares in the company, valued at $30,805,286.70. The trade was a 0.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.February 20 at 5:11 PM | marketbeat.comTKG Advisors LLC Raises Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)TKG Advisors LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 99.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,247 shares of the pharmaceutical company'sFebruary 20 at 7:10 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Cumberland Partners LtdCumberland Partners Ltd increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 47,326 shares of the pharmaceutical company's stock after buying an additional 4,126 shaFebruary 20 at 5:41 AM | marketbeat.comPrivate Wealth Partners LLC Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Private Wealth Partners LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 38.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,495 shares of the pharmaceutical company'sFebruary 20 at 5:24 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Position Boosted by Convergence Investment Partners LLCConvergence Investment Partners LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 109.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investorFebruary 20 at 4:45 AM | marketbeat.comKestra Investment Management LLC Decreases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Kestra Investment Management LLC cut its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 68.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 731 shares of the pharmaceutical company's sFebruary 20 at 4:28 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS reduced its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 66.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 665 shares of thFebruary 20 at 4:19 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-six brokerages that are currently covering the stock, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold rating, fifteen have giFebruary 20 at 2:35 AM | marketbeat.comVertex Pharmaceuticals Inc (VRTX) Announces Participation in Upcoming Investor ConferencesFebruary 19 at 5:08 PM | gurufocus.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by New York State Common Retirement FundNew York State Common Retirement Fund increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 362,334 shares ofFebruary 19 at 5:40 AM | marketbeat.comBlue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceuFebruary 19 at 3:55 AM | marketbeat.comHigh-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment modelsFebruary 18 at 9:52 AM | cnbc.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Davidson Investment AdvisorsDavidson Investment Advisors boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 26.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,161 shares of the pharmaceutical cFebruary 18 at 7:19 AM | marketbeat.comKentucky Retirement Systems Insurance Trust Fund Acquires 636 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Kentucky Retirement Systems Insurance Trust Fund lifted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,February 18 at 7:11 AM | marketbeat.comBraun Stacey Associates Inc. Sells 6,047 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Braun Stacey Associates Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 45,450 shares of the pharmaceutical company's stock after selling 6,047 sharesFebruary 18 at 6:11 AM | marketbeat.comVenturi Wealth Management LLC Acquires 3,580 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Venturi Wealth Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 141.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,112 shares of the pharmaceFebruary 18 at 5:44 AM | marketbeat.comTruist Financial Corp Boosts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Truist Financial Corp raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 211,804 shFebruary 18 at 5:24 AM | marketbeat.comCIBC Asset Management Inc Increases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CIBC Asset Management Inc lifted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,491 sFebruary 18 at 5:16 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Raised by Sanctuary Advisors LLCSanctuary Advisors LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,831 shares of the pharmaceuFebruary 18 at 5:09 AM | marketbeat.comPrincipal Financial Group Inc. Sells 13,827 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Principal Financial Group Inc. trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 396,532 shares of the pharmaceutical company's stock after seFebruary 18 at 4:59 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Baillie Gifford & Co.Baillie Gifford & Co. boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 149,838 shares of the pharmaceutical company's stocFebruary 18 at 4:49 AM | marketbeat.comCsenge Advisory Group Trims Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Csenge Advisory Group reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,144 shares of the pharmaceutical company's stoFebruary 18 at 4:24 AM | marketbeat.comPrincipal Securities Inc. Has $2.20 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Principal Securities Inc. increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,463 shares of the pharmaceutical companyFebruary 18 at 4:15 AM | marketbeat.comAlphaCentric Advisors LLC Invests $1.25 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)AlphaCentric Advisors LLC bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 3,101 shares of the pharmaceutical company's stock, valued at approximately $1,February 17, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Americana Partners LLCAmericana Partners LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 12,145 shares of the pharmaceutical company's stock after purchasing an additional 897 sFebruary 17, 2025 | marketbeat.com3 Stocks That Could Trounce the Market in 2025February 17, 2025 | fool.comKessler Investment Group LLC Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Kessler Investment Group LLC lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 90.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,373 shares of the pharmaceutical comFebruary 16, 2025 | marketbeat.comRhumbline Advisers Sells 7,335 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Rhumbline Advisers lessened its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 442,361 shares of the pharmaceutical companFebruary 16, 2025 | marketbeat.comStrategic Financial Concepts LLC Makes New $8.11 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Strategic Financial Concepts LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 20,136 shares of the pharmaceuticalFebruary 16, 2025 | marketbeat.com3,750 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by ABC Arbitrage SAABC Arbitrage SA purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 3,750 shares of the pharmaceutical company's stocFebruary 16, 2025 | marketbeat.comLittle House Capital LLC Purchases 1,011 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Little House Capital LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,734 shares of the pharmaceutical coFebruary 16, 2025 | marketbeat.comAustralianSuper Pty Ltd Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)AustralianSuper Pty Ltd lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 219,075 shares of the pharmaceutical company's stock after sFebruary 16, 2025 | marketbeat.comCongress Asset Management Co. Reduces Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Congress Asset Management Co. reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 22.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 147,149 shares of the pharmaceutical company's stock after selling 4February 16, 2025 | marketbeat.com2 Healthcare Stocks That Tumbled in 2024February 15, 2025 | fool.comNew York State Teachers Retirement System Cuts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)New York State Teachers Retirement System lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 221,2February 15, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Position Reduced by Chevy Chase Trust Holdings LLCChevy Chase Trust Holdings LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investoFebruary 15, 2025 | marketbeat.comCompagnie Lombard Odier SCmA Has $3.85 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Compagnie Lombard Odier SCmA reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,565 shares of the pharmaceutical company'sFebruary 15, 2025 | marketbeat.comBogart Wealth LLC Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bogart Wealth LLC boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 15.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,259 shares of the pharmaceutical company's stock afFebruary 15, 2025 | marketbeat.comVontobel Holding Ltd. Acquires 75,653 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Vontobel Holding Ltd. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 66.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 188,949 shares of the pharmaceuFebruary 15, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Mcrae Capital Management Inc.Mcrae Capital Management Inc. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,078 shares of theFebruary 15, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Banque Pictet & Cie SABanque Pictet & Cie SA grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 7.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,043 shares of the pharmaceutical company's stock afterFebruary 15, 2025 | marketbeat.comVertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock SkyrocketingFebruary 15, 2025 | finance.yahoo.comAllspring Global Investments Holdings LLC Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Allspring Global Investments Holdings LLC lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 59.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,626 shares of tFebruary 15, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.200.60▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼5422▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Neurocrine Biosciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
